Authors:
BERRIDGE MS
HEALD DL
MUSWICK GJ
LEISURE GP
VOELKER KW
MIRALDI F
Citation: Ms. Berridge et al., BIODISTRIBUTION AND KINETICS OF NASAL CARBON-11-TRIAMCINOLONE ACETONIDE, The Journal of nuclear medicine, 39(11), 1998, pp. 1972-1977
Citation: Dl. Heald et al., LUNG DEPOSITION OF TRIAMCINOLONE ACETONIDE WITH AND WITHOUT THE INTEGRATED SPACER AS DETERMINED BY POSITRON-EMISSION-TOMOGRAPHY AND SPIRAL CT, Journal of allergy and clinical immunology, 101(1), 1998, pp. 38-38
Authors:
BERRIDGE MS
MUSWICK GJ
LEE Z
LEISURE GP
NELSON AD
MUZIC RF
MIRALDI F
HEALD DL
Citation: Ms. Berridge et al., PET EVALUATION OF AZMACORT ([C-11]TRIAMCINOLONE ACETONIDE) DOSE ADMINISTRATION, The Journal of nuclear medicine, 38(5), 1997, pp. 7-7
Authors:
PENTIKIS HS
JOHNSON RD
HUANG MY
JENSEN BK
HEALD DL
DORR MB
TALBOT GH
Citation: Hs. Pentikis et al., POPULATION PHARMACOKINETIC ANALYSIS OF SPARFLOXACIN PLASMA-CONCENTRATIONS OBTAINED IN PHASE-III CLINICAL-TRIALS, Clinical pharmacology and therapeutics, 59(2), 1996, pp. 70-70
Authors:
WILDING IR
DAVIS SS
SPARROW RA
ZIEMNIAK JA
HEALD DL
Citation: Ir. Wilding et al., PHARMACOSCINTIGRAPHIC EVALUATION OF A MODIFIED RELEASE (GEOMATRIX(R))DILTIAZEM FORMULATION, Journal of controlled release, 33(1), 1995, pp. 89-97
Authors:
HEALD DL
BEDNARCZYK EM
BORDEAUX K
BERRIDGE M
KOCH T
OBETZ C
ZIEMNIAK J
MUSWICK G
KIM SL
Citation: Dl. Heald et al., REGIONAL DISTRIBUTION OF C-11 LABELED TRIAMCINOLONE ACETONIDE FOLLOWING INTRANASAL ADMINISTRATION IN HEALTHY-VOLUNTEERS, Clinical pharmacology and therapeutics, 55(2), 1994, pp. 183-183